Cargando…

Associations of Fentanyl, Sufentanil, and Remifentanil With Length of Stay and Mortality Among Mechanically Ventilated Patients: A Registry-Based Cohort Study

Background: As the first-line treatment for mechanically ventilated patients with critical illness, fentanyl and its analogs (e.g., sufentanil and remifentanil) are commonly used in the intensive care unit (ICU). However, the pharmacokinetics, metabolism, and potency of these agents differed. Their...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Wen, He, Qiao, Wang, Mingqi, Kang, Yan, Ji, Peng, Zhu, Shichao, Zhang, Rui, Zou, Kang, Sun, Xin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8931505/
https://www.ncbi.nlm.nih.gov/pubmed/35308226
http://dx.doi.org/10.3389/fphar.2022.858531
_version_ 1784671280729948160
author Wang, Wen
He, Qiao
Wang, Mingqi
Kang, Yan
Ji, Peng
Zhu, Shichao
Zhang, Rui
Zou, Kang
Sun, Xin
author_facet Wang, Wen
He, Qiao
Wang, Mingqi
Kang, Yan
Ji, Peng
Zhu, Shichao
Zhang, Rui
Zou, Kang
Sun, Xin
author_sort Wang, Wen
collection PubMed
description Background: As the first-line treatment for mechanically ventilated patients with critical illness, fentanyl and its analogs (e.g., sufentanil and remifentanil) are commonly used in the intensive care unit (ICU). However, the pharmacokinetics, metabolism, and potency of these agents differed. Their effects on clinical outcomes have not been well-understood. Materials and Methods: Using a well-established registry, we conducted a cohort study. Patients who consistently underwent mechanical ventilation (MV) for more than 24 h were identified. We used a time-varying exposure definition, in which we coded each type of opioids as prescribed or not prescribed on each day from initiation of MV to extubation and ICU discharge. We used Fine-Gray competing risk models to compare the effects of fentanyl, sufentanil, and remifentanil on hazards for extubation, ventilator mortality, ICU discharge, and ICU mortality. All models were adjusted using a combination of fixed-time and time-varying covariates. Missing data were imputed using multiple imputation by chained equations. Results: A total of 8,165 patients were included. There were, respectively, 4,778, 4,008, and 2,233 patients receiving at least 1 day of fentanyl, sufentanil, and remifentanil dose. Compared to fentanyl, sufentanil was associated with shorter duration to extubation (hazard ratio 1.31, 95% CI, 1.20–1.41) and ICU discharge (hazard ratio 1.63, 95% CI, 1.38–1.92), and remifentanil was associated with shorter duration to extubation (hazard ratio 1.60, 95% CI, 1.40–1.84) and ICU discharge (hazard ratio 2.02, 95% CI, 1.43–2.84). No significant differences in time to extubation (Hazard ratio 1.14, 95% CI, 0.92–1.41) and ICU discharge (Hazard ratio 1.31, 95% CI, 0.81–2.14) were found between sufentanil and remifentanil. No differences were observed between any two of the agents regarding ventilator mortality or ICU mortality. The effects were similar in patients with versus without surgery. Conclusion: Sufentanil and remifentanil may be superior to fentanyl in shortening the time to extubation and ICU discharge. The effects on ventilator mortality and ICU mortality appeared similar across these agents, while further research is warranted.
format Online
Article
Text
id pubmed-8931505
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-89315052022-03-19 Associations of Fentanyl, Sufentanil, and Remifentanil With Length of Stay and Mortality Among Mechanically Ventilated Patients: A Registry-Based Cohort Study Wang, Wen He, Qiao Wang, Mingqi Kang, Yan Ji, Peng Zhu, Shichao Zhang, Rui Zou, Kang Sun, Xin Front Pharmacol Pharmacology Background: As the first-line treatment for mechanically ventilated patients with critical illness, fentanyl and its analogs (e.g., sufentanil and remifentanil) are commonly used in the intensive care unit (ICU). However, the pharmacokinetics, metabolism, and potency of these agents differed. Their effects on clinical outcomes have not been well-understood. Materials and Methods: Using a well-established registry, we conducted a cohort study. Patients who consistently underwent mechanical ventilation (MV) for more than 24 h were identified. We used a time-varying exposure definition, in which we coded each type of opioids as prescribed or not prescribed on each day from initiation of MV to extubation and ICU discharge. We used Fine-Gray competing risk models to compare the effects of fentanyl, sufentanil, and remifentanil on hazards for extubation, ventilator mortality, ICU discharge, and ICU mortality. All models were adjusted using a combination of fixed-time and time-varying covariates. Missing data were imputed using multiple imputation by chained equations. Results: A total of 8,165 patients were included. There were, respectively, 4,778, 4,008, and 2,233 patients receiving at least 1 day of fentanyl, sufentanil, and remifentanil dose. Compared to fentanyl, sufentanil was associated with shorter duration to extubation (hazard ratio 1.31, 95% CI, 1.20–1.41) and ICU discharge (hazard ratio 1.63, 95% CI, 1.38–1.92), and remifentanil was associated with shorter duration to extubation (hazard ratio 1.60, 95% CI, 1.40–1.84) and ICU discharge (hazard ratio 2.02, 95% CI, 1.43–2.84). No significant differences in time to extubation (Hazard ratio 1.14, 95% CI, 0.92–1.41) and ICU discharge (Hazard ratio 1.31, 95% CI, 0.81–2.14) were found between sufentanil and remifentanil. No differences were observed between any two of the agents regarding ventilator mortality or ICU mortality. The effects were similar in patients with versus without surgery. Conclusion: Sufentanil and remifentanil may be superior to fentanyl in shortening the time to extubation and ICU discharge. The effects on ventilator mortality and ICU mortality appeared similar across these agents, while further research is warranted. Frontiers Media S.A. 2022-03-04 /pmc/articles/PMC8931505/ /pubmed/35308226 http://dx.doi.org/10.3389/fphar.2022.858531 Text en Copyright © 2022 Wang, He, Wang, Kang, Ji, Zhu, Zhang, Zou and Sun. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Pharmacology
Wang, Wen
He, Qiao
Wang, Mingqi
Kang, Yan
Ji, Peng
Zhu, Shichao
Zhang, Rui
Zou, Kang
Sun, Xin
Associations of Fentanyl, Sufentanil, and Remifentanil With Length of Stay and Mortality Among Mechanically Ventilated Patients: A Registry-Based Cohort Study
title Associations of Fentanyl, Sufentanil, and Remifentanil With Length of Stay and Mortality Among Mechanically Ventilated Patients: A Registry-Based Cohort Study
title_full Associations of Fentanyl, Sufentanil, and Remifentanil With Length of Stay and Mortality Among Mechanically Ventilated Patients: A Registry-Based Cohort Study
title_fullStr Associations of Fentanyl, Sufentanil, and Remifentanil With Length of Stay and Mortality Among Mechanically Ventilated Patients: A Registry-Based Cohort Study
title_full_unstemmed Associations of Fentanyl, Sufentanil, and Remifentanil With Length of Stay and Mortality Among Mechanically Ventilated Patients: A Registry-Based Cohort Study
title_short Associations of Fentanyl, Sufentanil, and Remifentanil With Length of Stay and Mortality Among Mechanically Ventilated Patients: A Registry-Based Cohort Study
title_sort associations of fentanyl, sufentanil, and remifentanil with length of stay and mortality among mechanically ventilated patients: a registry-based cohort study
topic Pharmacology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8931505/
https://www.ncbi.nlm.nih.gov/pubmed/35308226
http://dx.doi.org/10.3389/fphar.2022.858531
work_keys_str_mv AT wangwen associationsoffentanylsufentanilandremifentanilwithlengthofstayandmortalityamongmechanicallyventilatedpatientsaregistrybasedcohortstudy
AT heqiao associationsoffentanylsufentanilandremifentanilwithlengthofstayandmortalityamongmechanicallyventilatedpatientsaregistrybasedcohortstudy
AT wangmingqi associationsoffentanylsufentanilandremifentanilwithlengthofstayandmortalityamongmechanicallyventilatedpatientsaregistrybasedcohortstudy
AT kangyan associationsoffentanylsufentanilandremifentanilwithlengthofstayandmortalityamongmechanicallyventilatedpatientsaregistrybasedcohortstudy
AT jipeng associationsoffentanylsufentanilandremifentanilwithlengthofstayandmortalityamongmechanicallyventilatedpatientsaregistrybasedcohortstudy
AT zhushichao associationsoffentanylsufentanilandremifentanilwithlengthofstayandmortalityamongmechanicallyventilatedpatientsaregistrybasedcohortstudy
AT zhangrui associationsoffentanylsufentanilandremifentanilwithlengthofstayandmortalityamongmechanicallyventilatedpatientsaregistrybasedcohortstudy
AT zoukang associationsoffentanylsufentanilandremifentanilwithlengthofstayandmortalityamongmechanicallyventilatedpatientsaregistrybasedcohortstudy
AT sunxin associationsoffentanylsufentanilandremifentanilwithlengthofstayandmortalityamongmechanicallyventilatedpatientsaregistrybasedcohortstudy